UK markets closed

Pieris Pharmaceuticals, Inc. (PIRS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
11.15-0.01 (-0.09%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
47,357
25,902
31,418
29,323
Operating expenses
Research development
50,727
52,982
66,656
46,531
Selling general and administrative
18,511
16,394
16,593
16,713
Total operating expenses
62,235
61,203
79,564
63,244
Operating income or loss
-14,878
-35,301
-48,146
-33,921
Total other income/expenses net
-14,930
1,303
2,404
-3,656
Income before tax
-28,061
-33,277
-45,738
-37,066
Income tax expense
-
-
0
164
Income from continuing operations
-28,061
-33,277
-45,738
-37,230
Net income
-28,061
-33,277
-45,738
-37,230
Net income available to common shareholders
-28,061
-33,277
-45,738
-37,230
Basic EPS
-0.34
-36.00
-56.80
-54.40
Diluted EPS
-0.34
-36.00
-56.80
-54.40
Basic average shares
83,932
927.15
806.837
681.012
Diluted average shares
83,932
927.15
806.837
681.012